ストックスクリーナーアプリを入手
52.73
0.05%
0.02
前日終値:
$52.71
開ける：
$52.73
24時間の取引高:
348.41K
Relative Volume:
0.07
時価総額：
$6.09B
収益：
-
当期純損益:
$-96.21M
株価収益率:
-51.07
EPS:
-1.0326
ネットキャッシュフロー:
$-82.18M
1週間 パフォーマンス:
+0.33%
1か月 パフォーマンス:
+14.47%
6か月 パフォーマンス:
+512.49%
1年 パフォーマンス:
+2,254%
1日の値動き範囲:
$52.71
$52.74
1週間の範囲:
$52.60
$52.76
52週間の値動き範囲:
$2.23
$53.19
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
名前
Terns Pharmaceuticals Inc
セクター
電話
650-525-5535 EXT.101
住所
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Compare TERN vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
52.73 | 6.08B | 0 | -96.21M | -82.18M | -1.0326 |
VRTX
Vertex Pharmaceuticals Inc
|
442.42 | 112.35B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
754.04 | 79.71B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
835.08 | 52.29B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.55 | 44.48B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
321.98 | 35.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-25 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2026-02-09 | 開始されました | Leerink Partners | Outperform |
| 2025-11-04 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2025-11-03 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2025-10-15 | 開始されました | Truist | Buy |
| 2025-09-17 | 開始されました | Barclays | Overweight |
| 2025-09-04 | 再開されました | H.C. Wainwright | Neutral |
| 2025-02-28 | 開始されました | William Blair | Mkt Perform |
| 2024-10-31 | 開始されました | Oppenheimer | Outperform |
| 2023-06-22 | 開始されました | Mizuho | Buy |
| 2023-06-07 | 開始されました | Jefferies | Buy |
| 2023-05-31 | 開始されました | ROTH MKM | Buy |
| 2023-05-08 | 開始されました | BMO Capital Markets | Outperform |
| 2023-02-14 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-02-07 | 開始されました | UBS | Buy |
| 2022-09-12 | 開始されました | H.C. Wainwright | Neutral |
| 2021-09-14 | 再開されました | Goldman | Buy |
| 2021-03-02 | 開始されました | Cowen | Outperform |
| 2021-03-02 | 開始されました | Goldman | Buy |
| 2021-03-02 | 開始されました | JP Morgan | Overweight |
すべてを表示
Terns Pharmaceuticals Inc (TERN) 最新ニュース
This Terns Pharmaceuticals analyst is no longer bullish; here are top 4 downgrades for Monday - MSN
Merck to acquire Terns Pharmaceuticals for $53 per share in cash - MSN
Merck to buy Terns for $6.7 billion to grow in blood cancers - MSN
TERN Maintained by JP Morgan -- Price Target Raised to $44.50 - GuruFocus
Merck's $6.7 billion Terns Pharmaceuticals acquisition may face rival interest: Analyst - MSN
Wall Street Recap: Is Terns Pharmaceuticals Inc a top pick in the sector2026 Trading Volume Trends & Weekly Stock Performance Updates - baoquankhu1.vn
TERN Stock Chart | TERNS PHARMACEUTICALS INC (NASDAQ:TERN) - ChartMill
Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B - MSN
TERN PE Ratio & Valuation, Is TERN Overvalued - Intellectia AI
TERN SEC FilingsTerns Pharmaceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti Investigates Proposed Sale - National Today
User - The Chronicle-Journal
Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? - Finviz
Merck nears $6 billion deal to buy Terns Pharma: Report - MSN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Terns Therapeutics, Inc. (Nasdaq – TERN), Whitestone REIT (NYSE – WSR), Rallybio Corporation (Nasdaq – RLYB), Day One Biopharmaceuticals, Inc. (Nasda - ChartMill
Merck & Co. Deepens Hematology Pipeline with $6.7 Billion Terns Acquisition - CHEManager.
Merck begins tender offer to buy Terns Pharmaceuticals - MSN
TERN Stock Price, Quote & Chart | TERNS PHARMACEUTICALS INC (NASDAQ:TERN) - ChartMill
Merck & Co Inc Stock (MRK) Moved Up by 3.18% on Apr 8: Facts Behind the Movement - TradingKey
$680 Million in Daily Turnover Crowns Terns as Most Active Stock Ahead of Merck Deal - Bitget
How Merck slashed its bid for Terns Pharmaceuticals by $1B after reviewing cancer drug trial data - The Business Journals
Why Terns Pharmaceuticals Stock Rocked the Market in March - The Globe and Mail
Mizuho reiterates Terns Pharmaceuticals stock rating at Neutral By Investing.com - Investing.com Canada
Terns’ drug may not be as competitive as many initially thought - statnews.com
Mizuho reiterates Terns Pharmaceuticals stock rating at Neutral - Investing.com
Leerink Partners Downgrades Terns Pharmaceuticals(TERN.US) to Hold Rating - Moomoo
Merck moves to seal $53-a-share takeover of Terns Pharmaceuticals - Indian Pharma Post
Merck Lowered Terns Pharmaceuticals Offer Price After Trial Data Review - Sahm
Merck’s US$6.7b Terns Deal And What It Means For Valuation - Sahm
Merck’s (NYSE:MRK) Terns Deal And S&P 500 Valuation Impact Explained - Kalkine Media
William Blair Downgrades Terns Pharmaceuticals(TERN.US) to Hold Rating, Announces Target Price $53 - Moomoo
William Blair downgrades Terns Pharmaceuticals stock rating on Merck deal By Investing.com - Investing.com Canada
Merck To Acquire Terns Pharmaceuticals - citybiz
What's Going On With Merck Stock Tuesday? - Benzinga
Terns rebuffed a higher bid before selling to Merck - BioPharma Dive
Merck (MRK) Initiates Tender Offer for Terns Pharmaceuticals - GuruFocus
Merck begins tender offer to buy Terns Pharmaceuticals (MRK:NYSE) - Seeking Alpha
Merck begins tender offer to acquire Terns Pharmaceuticals, Inc. - marketscreener.com
Merck launches tender offer to acquire Terns Pharmaceuticals for $53 per share - StreetInsider
Merck Begins Tender Offer To Acquire Terns Pharmaceuticals, Inc. - TradingView — Track All Markets
Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc. - Bluefield Daily Telegraph
[SC 14D9] Terns Pharmaceuticals, Inc. Tender Offer Recommendation - Stock Titan
Merck (NYSE: TERN) to acquire Terns for $53.00 per share cash - Stock Titan
Shareholder Alert: Ademi LLP investigates whether Terns Pharmaceuticals Inc. is obtaining a ... - Bluefield Daily Telegraph
Shareholder Alert: Ademi LLP investigates whether Terns - GlobeNewswire
Merck nears deal to buy Terns Pharmaceuticals - MSN
43,857 Shares in Terns Pharmaceuticals, Inc. $TERN Acquired by SG Americas Securities LLC - MarketBeat
Capricorn Fund Managers Ltd Takes $6.12 Million Position in Terns Pharmaceuticals, Inc. $TERN - MarketBeat
Terns Pharmaceuticals Inc (TERN) 財務データ
収益
当期純利益
現金流量
EPS
1.12%
0.31%
大文字化:
|
ボリューム (24 時間):